Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

To date the true global incidence of intrahepatic cholangiocarcinoma (iCCA) and the
underlying risk factors remain to be fully defined, in particular, the role of occupational and …

Background Hepatectomy is the cornerstone of curative-intent treatment for intrahepatic
cholangiocarcinoma (ICC). However, in patients unable to be resected, data comparing …

Objectives The role of laparoscopic hepatectomy (LH) for intrahepatic cholangiocarcinoma
(ICC) remains indefinite, though the utilization of this minimally invasive approach has been …

Background Qualifying comorbidity sets (QCS) are tools used to identify multimorbid patients
at increased surgical risk. It is unknown how the QCS framework for multimorbidity affects …

Background Curative surgical treatments afford the best prognosis for patients with
intrahepatic cholangiocarcinoma (iCCA); however, the comparative effectiveness of …

Cholangiocarcinoma is a spectrum of invasive adenocarcinomas that arise in the
intrahepatic, perihilar, or distal biliary tree, and is classified by location. During JADPRO Live …

Background Biliary tract cancers (BTC) have a limited prognosis even for localized cancers,
emphasizing the importance of multidisciplinary management. NCCN guidelines …

Background Advanced cholangiocarcinoma (CCA) is associated with considerable
morbidity and mortality. Novel second-line treatments for advanced CCA underscore the …

Background Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy
of the liver and has the worst prognosis of any tumor arising from the liver, with a 5‐year …